Integrated Rehabilitation in Treating Post-stroke Depression

Status Recruiting

Clinical Trial Summary

Post-stroke depression (PSD) is a common complication of stroke that leads to dysfunction and reduces the quality of life. PSD exacerbates cognitive dysfunction, delays the recovery process, and increases the disability, mortality and recurrence rates of stroke. Therefore, early clinical treatments for PSD are important to improve the prognosis and restore the social functions of stroke patients. Integrated rehabilitation has significant advantages in the treatment of PSD. First of all, there is a wide range of rehabilitation methods, such as acupuncture, traditional Chinese medicine, and repetitive transcranial magnetic stimulation, which have been proved to be effective for PSD. However, as the application of integrated rehabilitation becomes more and more widespread, its shortcomings are gradually emerging. For example, most of the treatment protocols used in clinical studies are based on personal experience of the investigators, a unified protocol has not yet been formed; treatment methods are still insufficient in standardization and reproducibility. More studies focus solely on the improvement of a certain symptom by a certain rehabilitation therapy, but ignore the important theoretical basis of the "holistic concept", thus showing the uneven clinical efficacy. For the above existing problems, it is necessary to conduct original and innovative research.

Clinical Trial Description

This randomized controlled trial will enroll 202 PSD patients from the Third Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang General Hospital of Armed Police, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, and Jinhua Second Hospital. All patients will be randomly assigned to either the integrated rehabilitation group or the standard care group through a randomization system. The primary outcome will be assessed by hamilton depression (HAMD) scale, self-rating depression scale (SDS), and activity of daily living (ADL) scale. Secondary outcomes will include montreal cognitive assessment (MoCA) scale, the simple fugl-meyer assessment of motor function (FMA) scale and pittsburgh sleep quality index (PSQI). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05187975
Study type	Interventional
Source	The Third Affiliated hospital of Zhejiang Chinese Medical University
Contact	Hong Gao
Phone	+8618072982566
Email	qtgh@vip.qq.com
Status	Recruiting
Phase	N/A
Start date	January 24, 2022
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05612659` - Developing an EEG Probe for Studying and Modulating Cognitive Control	N/A
Active, not recruiting	`NCT06451965` - SCED - Wisdom Enhancement for Post-Stroke Depression	N/A
Completed	`NCT04093843` - TMS for Post Stroke Depression	N/A
Recruiting	`NCT05516680` - Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD	N/A
Recruiting	`NCT04876066` - Use of Transmucosal Ketamine in Post Stroke Depression	Phase 1
Recruiting	`NCT03159351` - The Antidepressant Effects of rTMS After Ischemic Stroke	N/A
Recruiting	`NCT03864484` - iPad Application-based Intervention for Post-stroke Depression	N/A
Recruiting	`NCT05310175` - Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression	N/A
Completed	`NCT03639259` - Emotional and Cognitive Determinants of Post-stroke Fatigue
Completed	`NCT02472613` - Acupuncture for Ischemic Post-stroke Depression	N/A
Completed	`NCT04008719` - ATtention Test and Executive Functions After STroke to Predict Depression.	N/A
Recruiting	`NCT05241782` - The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients	N/A
Withdrawn	`NCT03761303` - rTMS as an add-on Therapy in Patients With Post-stroke Depression	N/A
Completed	`NCT04318951` - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia	N/A
Completed	`NCT04560413` - Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients
Completed	`NCT06157333` - Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression	N/A
Completed	`NCT03829397` - To Investigate the Correlation of Stroke Patients and Demoralized
Recruiting	`NCT03256305` - A Study of rTMS Personalized Precision Treatment of Post-stroke Depression	N/A
Recruiting	`NCT03789994` - Affective Touching on Poststroke Depression	N/A
Completed	`NCT05932550` - Safety of Maraviroc for Post-stroke Depression	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Integrated Rehabilitation in Treating Post-stroke Depression — IRTPD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms